Carregant...
Very low LDL‐C levels may safely provide additional clinical cardiovascular benefit: the evidence to date
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death in Europe and increased low‐density lipoprotein cholesterol (LDL‐C) is a major contributor to CVD risk. Extensive evidence from clinical studies of statins has demonstrated a linear relationship between LDL‐C levels and CVD risk....
Guardat en:
| Publicat a: | Int J Clin Pract |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215677/ https://ncbi.nlm.nih.gov/pubmed/27739167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12881 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|